Linustedastat clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How each study uses linustedastat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- OG-6219
- 1
Studies by the year they started
3 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses linustedastat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related PainCompletedPhase 2Organon and CoNCT05560646Written as OG-6219
- A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet FormulationsCompletedPhase 1Forendo Pharma LtdNCT04686669Written as FOR-6219 capsule formulation
- A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219CompletedPhase 1Forendo Pharma LtdNCT03709420Written as FOR-6219
Codes
What other systems call linustedastat · ClinicalTrials.gg INT017602
- UNII (FDA) PP3PLL7GZYLINUSTEDASTATConfirmed FDA, Wikidata
- Wikidata Q130052333linustedastatConfirmed FDA, Wikidata
- NCI Thesaurus C206932LinustedastatOne source FDA
- DrugBank DB21729One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | PP3PLL7GZY | LINUSTEDASTAT | Confirmed FDA, Wikidata |
| Wikidata | Q130052333 | linustedastat | Confirmed FDA, Wikidata |
| NCI Thesaurus | C206932 | Linustedastat | One source FDA |
| DrugBank | DB21729 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.